Literature DB >> 2254300

Characterization of the apolipoprotein B mRNA editing activity in enterocyte extracts.

D M Driscoll1, E Casanova.   

Abstract

Apolipoprotein B (apoB) circulates in human plasma as two isoforms, apoB-100 (512 kDa) and apoB-48 (242 kDa). ApoB-48 is generated by a novel RNA editing mechanism which post-transcriptionally modifies apoB mRNA in the intestine by converting cytidine at nucleotide 6666 to uridine. This converts codon 2153 from glutamine (CAA) to a premature stop codon (UAA). To characterize the activity which edits apoB mRNA, extracts were prepared from enterocytes isolated from baboon small intestine. These extracts efficiently edit synthetic apoB RNA in vitro. Editing was detected by primer extension, and the specificity of the reaction was confirmed by DNA sequencing. Extracts prepared from other baboon tissues did not edit apoB RNA in vitro. The editing activity was partially purified by chromatography of the enterocyte extracts on DEAE-cellulose. The activity is sensitive to proteinase K but resistant to micrococcal nuclease and has an average molecular mass of 125 kDa when analyzed by gel filtration chromatography.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2254300

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Characterization of the apolipoprotein B mRNA editing enzyme: no similarity to the proposed mechanism of RNA editing in kinetoplastid protozoa.

Authors:  J Greeve; N Navaratnam; J Scott
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

2.  Identification of the yeast cytidine deaminase CDD1 as an orphan C-->U RNA editase.

Authors:  G S Dance; P Beemiller; Y Yang; D V Mater; I S Mian; H C Smith
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

3.  Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.

Authors:  A Mehta; M T Kinter; N E Sherman; D M Driscoll
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

4.  APOBEC-1 dependent cytidine to uridine editing of apolipoprotein B RNA in yeast.

Authors:  G S Dance; M P Sowden; Y Yang; H C Smith
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

5.  Molecular cloning of a human small intestinal apolipoprotein B mRNA editing protein.

Authors:  C Hadjiagapiou; F Giannoni; T Funahashi; S F Skarosi; N O Davidson
Journal:  Nucleic Acids Res       Date:  1994-05-25       Impact factor: 16.971

6.  Apolipoprotein B mRNA editing is associated with UV crosslinking of proteins to the editing site.

Authors:  N Navaratnam; R Shah; D Patel; V Fay; J Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

7.  Autoimmune diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha (Lyt3.1) alleles of CD8.

Authors:  J M Johnson-Tardieu; E W Walworth; J G Cornelius; X Ye; S M Schuster; A B Peck
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

8.  Dimeric structure of a human apolipoprotein B mRNA editing protein and cloning and chromosomal localization of its gene.

Authors:  P P Lau; H J Zhu; A Baldini; C Charnsangavej; L Chan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

9.  Induction of RNA editing at heterologous sites by sequences in apolipoprotein B mRNA.

Authors:  D M Driscoll; S Lakhe-Reddy; L M Oleksa; D Martinez
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

10.  A sequence-specific RNA-binding protein complements apobec-1 To edit apolipoprotein B mRNA.

Authors:  A Mehta; D M Driscoll
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.